|Articles|November 1, 2022
Supplements and Featured Publications
- Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
- Volume 28
- Issue 12
Biosimilar medicines: what are they and how are they used?
Plain Language Summary
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
3
Missed Hepatitis B Treatment Opportunities in the US Increase Health Risks
4
Barriers to Treatment in Pediatric Myasthenia Gravis: Jonathan Strober, MD
5











































